CANCER CENTER ADMINISTRATION - ABSTRACT Administration at the Karmanos Cancer Institute (KCI) provides support to the Cancer Center leadership, Research Program and Shared Resource infrastructure, KCI membership, and staff by providing services aimed at relieving the administrative burden associated with research. Administration contributes to the mission of the Cancer Center by providing efficient management of resources, facilitating key internal and external scientific meetings, strategic planning, and developing useful metrics to aid in the decision making of KCI senior leadership. Mr. Evano Piasentin, Associate Center Director for Research Administration, leads an experienced administrative team. Administration supports 135 scientific members across four research Programs and nine Shared Resources (including one under development). Additionally, Administration manages extramural funding of $63 million (annual direct costs), KCI?s annual research budget of $21 million, and coordinated internal pilot funding of more than $2 million since the last renewal. Notable achievements during the past funding period include a restructuring of the administrative office to capitalize on the unique skills of staff and provide a more efficient and dynamic environment to meet the needs of the Cancer Center. Additionally, Administration supported the planning, process, and development of a new strategic plan through organization of strategic planning retreats convening stakeholders from various disciplines across KCI. The strategic plan is centered on five priority areas: immunology and immunotherapy, cancer metabolism and metabolomics, biology of cancer health disparities, addressing multilevel determinants of risk and survivorship, and increasing interventional research to reduce disparities. Administration continues to implement significant upgrades to the Research Administration Application (RAA), a homegrown repository of CCSG data for KCI. With respect to space management, Administration managed a relocation of basic science laboratories from the outdated Prentis Cancer Research Building to the renovated Elliman Research Building. Finally, Administration played a central role in the development of several large, multi-PI project grants leading to the first-ever funded SPORE grant at KCI; The Michigan Prostate SPORE (P50CA186786).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-39
Application #
10088974
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-08-08
Project End
2025-11-30
Budget Start
2020-12-15
Budget End
2021-11-30
Support Year
39
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Thakur, Manish K; Heilbrun, Lance; Dobson, Kimberlee et al. (2018) Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer. Clin Genitourin Cancer 16:e695-e703
Feldmann, Daniel P; Cheng, Yilong; Kandil, Rima et al. (2018) In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells. J Control Release 276:50-58
Wang, Zhaoxian; Sau, Samaresh; Alsaab, Hashem O et al. (2018) CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer. Nanomedicine 14:1441-1454
Vaishampayan, Ulka (2018) Advantages and Adversities of the Weighted Toxicity Score. Clin Cancer Res 24:4918-4920
Kim, Seongho; Wong, Weng Kee (2018) Extended two-stage adaptive designs with three target responses for phase II clinical trials. Stat Methods Med Res 27:3628-3642
Ravindra, Manasa; Wilson, Mike R; Tong, Nian et al. (2018) Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor ? and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. J Med Chem 61:4228-4248
Beebe-Dimmer, Jennifer L; Albrecht, Terrance L; Baird, Tara E et al. (2018) The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population. Cancer Epidemiol Biomarkers Prev :
Ahmed, Zainab Sabry Othman; Li, Xin; Li, Feng et al. (2018) Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells. J Cell Biochem 119:9006-9016
Desai, Pinkal; Wallace, Robert; Anderson, Matthew L et al. (2018) An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohort. Cancer Med 7:2121-2130
White, Donna L; Hoogeveen, Ron C; Chen, Liang et al. (2018) A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med 7:2180-2191

Showing the most recent 10 out of 826 publications